Mar 06, 2017 13:34 pm UTC| Business
EWING, N.J., March 06, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced it will release its fourth quarter and full year 2016 financial results and recent operating progress before the market opens on Tuesday,...
Mar 06, 2017 13:34 pm UTC| Business
EWING, N.J., March 06, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced it will release its fourth quarter and full year 2016 financial results and recent operating progress before the market opens on Tuesday,...
Mar 06, 2017 13:34 pm UTC| Business
EWING, N.J., March 06, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced it will release its fourth quarter and full year 2016 financial results and recent operating progress before the market opens on Tuesday,...
Mar 06, 2017 13:34 pm UTC| Business
EWING, N.J., March 06, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced it will release its fourth quarter and full year 2016 financial results and recent operating progress before the market opens on Tuesday,...
Mar 06, 2017 13:33 pm UTC| Business
WIXOM, Mich., March 06, 2017 -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for...
Mar 06, 2017 13:33 pm UTC| Business
WIXOM, Mich., March 06, 2017 -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for...
Mar 06, 2017 13:33 pm UTC| Business
WIXOM, Mich., March 06, 2017 -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for...